Our group is interested in the areas of synthesis, catalysis and the design of molecular systems. We are developing new catalytic asymmetric carbon-carbon bond forming reactions to rapidly access complex molecules from simple molecules and apply these methods to the construction of important targets like natural products and clinically used drugs.
More specifically, the group has created Cu- and Rh-catalyzed asymmetric cross-coupling reactions, including new asymmetric variants of Suzuki–Miyaura coupling, enabling precise control over molecular architecture. Alongside method development, they conduct mechanistic studies to understand reaction pathways and the origins of asymmetric induction, guiding the design of improved ligands and catalysts. Their techniques have been applied to synthesize compounds such as fulvestrant, tafluprost, niraparib, and the taxol core.
We are always looking for new team members with experience in synthesis, asymmetric catalysis and mechanistic studies.
Please email us directly to find out more
Available opportunities for new DPhil (PhD) Students include:
Joining our group directly by applying to the department.
Joining the Centre for Doctoral Training in sustainable chemical synthesis (CSHP CDT) and selecting P10 "Rapid access to novel cyclobutanes via asymmetric cross-coupling reactions" in collaboration with J&J Innovative Medicine.
Joining the IMAT CDT and selecting P23 "Designing active matter via controlled molecular transport and oscillations" in collaboration with Matthew Langton.
